Language
中文
Leadership
  • Over 30 years of biotech and R&D experience
  • Co-founder and former CEO of a Nasdaq listed company
  • Former senior scientific management positions at Chiron (Novartis and Bayer) and Affymetrix (ThermoFisher)
  • Researcher, Pathology of Harvard Medical School, and Transplantation Center of Stanford Medical School
  • Bachelor of Medicine, Fudan University / Shanghai Medical College
  • PhD in Immuno-pharmacology, Medical College of Virginia
  • Over 17 issued patents and applications for advanced cell therapie
  • MD, PhD with over 25 years in academia and industry, extensive experience in cell&gene therapy, immuno-oncology, mAb and small molecules in Multi National Companies & biotech companies
  • Served as CMO of a Nasdaq listed CART and Gene therapy company as well as Executive Medical Director - Early and Late stage Hematology Lead at Amgen
  • Previous Global Development and APAC Biologics strategy Lead Oncology Development at Genentech / Roche
  • Served as Medical Director, Oncology and immuno-oncology at Pfizer, Late stage oncology development in global and regional roles
  • Graduated from University of Heidelberg/Germany Medical Schools
  • Extensive experience in healthcare investment with strong leadership roles
  • Served as President of Fosun Healthcare Holdings and Chief Representative of Fosun, New York
  • Co-founder of Locust Walk Capital, a global healthcare hedge fund in 2010
  • Former Healthcare Sector Head at Scopia Capital
  • Former Managing Director and Portfolio Manager at Great Point Partners
  • Board of Director of ViewRay Inc (Nasdaq: VRAY) and Alpha Healthcare Acquisition Corp; Industry Advisory Board of Flare Capital
  • MBA from The Wharton School, a PhD in Chemistry from City University of New York
  • Over 30 years of biotech and R&D experience
  • Co-founder and former CEO of a Nasdaq listed company
  • Former senior scientific management positions at Chiron (Novartis and Bayer) and Affymetrix (ThermoFisher)
  • Researcher, Pathology of Harvard Medical School, and Transplantation Center of Stanford Medical School
  • Bachelor of Medicine, Fudan University / Shanghai Medical College
  • PhD in Immuno-pharmacology, Medical College of Virginia
  • Over 17 issued patents and applications for advanced cell therapie
  • MD, PhD with over 25 years in academia and industry, extensive experience in cell&gene therapy, immuno-oncology, mAb and small molecules in Multi National Companies & biotech companies
  • Served as CMO of a Nasdaq listed CART and Gene therapy company as well as Executive Medical Director - Early and Late stage Hematology Lead at Amgen
  • Previous Global Development and APAC Biologics strategy Lead Oncology Development at Genentech / Roche
  • Served as Medical Director, Oncology and immuno-oncology at Pfizer, Late stage oncology development in global and regional roles
  • Graduated from University of Heidelberg/Germany Medical Schools
  • Extensive experience in healthcare investment with strong leadership roles
  • Served as President of Fosun Healthcare Holdings and Chief Representative of Fosun, New York
  • Co-founder of Locust Walk Capital, a global healthcare hedge fund in 2010
  • Former Healthcare Sector Head at Scopia Capital
  • Former Managing Director and Portfolio Manager at Great Point Partners
  • Board of Director of ViewRay Inc (Nasdaq: VRAY) and Alpha Healthcare Acquisition Corp; Industry Advisory Board of Flare Capital
  • MBA from The Wharton School, a PhD in Chemistry from City University of New York